Domain | No. Studies Assessing This Domain, n (%) | Most Frequent Instrument Used (no. studies) | Other Instruments Used (no. studies) |
---|---|---|---|
Laboratory markers of inflammation | 43/46 (93) | ESR/CRP (42) |
|
Pain | 32/46 (70) | VAS (29) |
|
Stiffness | 28/46 (63) | Morning stiffness duration in minutes (26) |
|
Physical function | 22/46 (48) | Elevation of upper limbs on 0–3 scale (13) |
|
Global assessment/disease activity | 21/46 (46) | PMR-AS (13) |
|
Imaging | 9/46 (2) | Ultrasound (6) |
|
Other | |||
Physical examination, presence of synovitis, fever, or weight loss | 10 | ||
No. relapses, duration of treatment, or cumulative steroid dose | 7 | ||
Other blood variables (e.g., FBC, HbA1c, ACTH/cortisol) | 17 | ||
Fatigue | 6 | VAS (4) |
|
Health status | 5 | Unspecified questionnaire/VAS (4) | Back-to-normal question (1) |
Mood/anxiety | 1 | GAD-738 (1) PHQ-839 (1) |
OMERACT core set domains in bold. CRP: C-reactive protein; ESR: erythrocyte sedimentation rate; FBC: full blood count; FDG-PET CT: fluorodeoxyglucose-positron emission tomography/computed tomography; GAD-7: Generalized Anxiety Disorder-7; HAQ: Health Assessment Questionnaire; IL: interleukin; MRI: magnetic resonance imaging; NRS: numeric rating scale; PGA: physician global assessment; PHQ-8: Patient Health Questionnaire-8; PMR-AS: Polymyalgia Rheumatica Activity Score; PtGA: patient global assessment; SF-36: 36-item Short Form Health Survey; TNF: tumor necrosis factor; VAS: visual analog scale.